Interleukin-7 and immunosenescence

Journal of Immunology Research

Volumn 2017, Issue , 2017, Pages

  Nguyen, Vanloan ^a   Mendelsohn, Andrew ^a   Larrick, James W ^a  

^a Panorama Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE RECEPTOR; CYTOKINE RECEPTOR LIKE FACTOR 2; GROWTH PROMOTOR; HYBRID PROTEIN; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; JANUS KINASE 1; JANUS KINASE 3; PRE PRO B CELL GROWTH STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 7; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

AGING; CELL AGING; CELL MATURATION; CELL REGENERATION; DNA DAMAGE; GENE EXPRESSION; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; IDIOPATHIC DISEASE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSENESCENCE; LONGEVITY; LYMPHOCYTOPENIA; LYMPHOPOIESIS; MALIGNANT NEOPLASM; MORTALITY; NONHUMAN; PRE B LYMPHOCYTE; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TELOMERE; THYMUS; ANIMAL; HOMEOSTASIS; IMMUNOLOGY; INFLAMMATION; MOUSE; PATHOPHYSIOLOGY;

AGING; ANIMALS; HOMEOSTASIS; HUMANS; IMMUNOSENESCENCE; INFLAMMATION; INTERLEUKIN-7; LONGEVITY; MICE; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION;

EID: 85018851870     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2017/4807853     Document Type: Review

References (163)

1. W. M. Passtoors, E. B. van den Akker, J. Deelen et al., "IL7R gene expression network associates with human healthy ageing, " Immunity & Ageing, vol. 12, p. 21, 2015.
2. C. Lopez-Otin, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, "The hallmarks of aging, " Cell, vol. 153, no. 6, pp. 1194-1217, 2013.
3. R. Mazzucchelli and S. K. Durum, "Interleukin-7 receptor expression: intelligent design, " Nature Reviews. Immunology, vol. 7, no. 2, pp. 144-154, 2007.
4. Y. Rochman, R. Spolski, and W. J. Leonard, "New insights into the regulation of T cells by gamma(c) family cytokines, " Nature Reviews. Immunology, vol. 9, no. 7, pp. 480-490, 2009.
5. R. Fernandez-Botran, "Soluble cytokine receptors: basic immunology and clinical applications, " Critical Reviews in Clinical Laboratory Sciences, vol. 36, no. 3, pp. 165-224, 1999.
6. R. Fernandez-Botran, F. A. Crespo, and X. Sun, "Soluble cytokine receptors in biological therapy, " Expert Opinion on Biological Therapy, vol. 2, no. 6, pp. 585-605, 2002.
7. F. C. McKay, L. I. Swain, S. D. Schibeci et al., "Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis, " Genes and Immunity, vol. 9, no. 1, pp. 1-6, 2008.
8. W. Lundstrom, S. Highfill, S. T. Walsh et al., "Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 19, pp. E1761-E1770, 2013.
9. H. Geiger and G. Van Zant, "The aging of lymphohematopoietic stem cells, " Nature Immunology, vol. 3, no. 4, pp. 329-333, 2002.
10. S. J. Morrison, A. M. Wandycz, K. Akashi, A. Globerson, and I. L. Weissman, "The aging of hematopoietic stem cells, " Nature Medicine, vol. 2, no. 9, pp. 1011-1016, 1996.
11. D. J. Rossi, D. Bryder, J. M. Zahn et al., "Cell intrinsic alterations underlie hematopoietic stem cell aging, " Proceedings of the National Academy of Sciences, vol. 102, no. 26, pp. 9194-9199, 2005.
12. V. Janzen, R. Forkert, H. E. Fleming et al., "Stem-cell ageing modified bythe cyclin-dependent kinase inhibitor p16INK4a, " Nature, vol. 443, no. 7110, pp. 421-426, 2006.
13. T. W. LeBien and T. F. Tedder, "B lymphocytes: how they develop and function, " Blood, vol. 112, no. 5, pp. 1570-1580, 2008.
14. I. L. Martensson, N. Almqvist, O. Grimsholm, and A. Bernardi, "The pre-B cell receptor checkpoint, " FEBS Letters, vol. 584, no. 12, pp. 2572-2579, 2010.
15. R. Pelanda and R. M. Torres, "Central B-cell tolerance: where selection begins, " Cold Spring Harbor Perspectives in Biology, vol. 4, no. 4, p. a007146, 2012.
16. S. A. Corfe, R. Rottapel, and C. J. Paige, "The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation, " Seminars in Immunology, vol. 24, no. 3, pp. 198-208, 2012.
17. S. A. Corfe, R. Rottapel, and C. J. Paige, "Modulation of IL-7 thresholds by SOCS proteins in developing B lineage cells, " Journal of Immunology, vol. 187, no. 7, pp. 3499-3510, 2011.
18. P. Szabo, K. Zhao, I. Kirman et al., "Maturation of B cell precursors is impaired in thymic-deprived nude and old mice, " Journal of Immunology, vol. 161, no. 5, pp. 2248-2253, 1998.
19. A. Ben-Yehuda, P. Szabo, and M. E. Weksler, "Age-associated changes in the B-cell repertoire: effect of age on RAG-1 gene expression in murine bone marrow, " Immunology Letters, vol. 40, no. 3, pp. 287-289, 1994.
20. J. E. Labrie 3rd, A. P. Sah, D. M. Allman, M. P. Cancro, and R. M. Gerstein, "Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice, " The Journal of Experimental Medicine, vol. 200, no. 4, pp. 411-423, 2004.
21. S. Han, K. Yang, Z. Ozen et al., "Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice, " Journal of Immunology, vol. 170, no. 3, pp. 1267-1273, 2003.
22. J. P. Miller and D. Allman, "The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors, " Journal of Immunology, vol. 171, no. 5, pp. 2326-2330, 2003.
23. R. P. Stephan, D. A. Lill-Elghanian, and P. L. Witte, "Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors, " Journal of Immunology, vol. 158, no. 4, pp. 1598-1609, 1997.
24. J. F. Miller, "Events that led to the discovery of T-cell development and function-a personal recollection, " Tissue Antigens, vol. 63, no. 6, pp. 509-517, 2004.
25. J. F. Miller, "Immunological function of the thymus, " Lancet, vol. 2, no. 7205, pp. 748-749, 1961.
26. M. Torroba and A. G. Zapata, "Aging of the vertebrate immune system, " Microscopy Research and Technique, vol. 62, no. 6, pp. 477-481, 2003.
27. R. L. Boyd, C. L. Tucek, D. I. Godfrey et al., "The thymic microenvironment, " Immunology Today, vol. 14, no. 9, pp. 445-459, 1993.
28. G. Anderson and E. J. Jenkinson, "Lymphostromal interactions in thymic development and function, " Nature Reviews. Immunology, vol. 1, no. 1, pp. 31-40, 2001.
29. D. I. Godfrey, J. Kennedy, T. Suda, and A. Zlotnik, "A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triplenegative adult mouse thymocytes defined by CD44 and CD25 expression, " Journal of Immunology, vol. 150, no. 10, pp. 4244-4252, 1993.
30. H. J. Fehling and H. von Boehmer, "Early alpha beta T cell development in the thymus of normal and genetically altered mice, " Current Opinion in Immunology, vol. 9, no. 2, pp. 263-275, 1997.
31. L. J. Berg and J. Kang, "Molecular determinants of TCR expression and selection, " Current Opinion in Immunology, vol. 13, no. 2, pp. 232-241, 2001.
32. L. Li, H. C. Hsu, W. E. Grizzle et al., "Cellular mechanism of thymic involution, " Scandinavian Journal of Immunology, vol. 57, no. 5, pp. 410-422, 2003.
33. G. G. Steinmann, B. Klaus, and H. K. Muller-Hermelink, "The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study, " Scandinavian Journal of Immunology, vol. 22, no. 5, pp. 563-575, 1985.
34. K. G. Flores, J. Li, G. D. Sempowski, B. F. Haynes, and L. P. Hale, "Analysis of the human thymic perivascular space during aging, " Journal of Clinical Investigation, vol. 104, no. 8, pp. 1031-1039, 1999.
35. J. M. Bertho, C. Demarquay, N. Moulian, A. Van Der Meeren, S. Berrih-Aknin, and P. Gourmelon, "Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life, " Cellular Immunology, vol. 179, no. 1, pp. 30-40, 1997.
36. D. C. Douek, R. D. McFarland, P. H. Keiser et al., "Changes in thymic function with age and during the treatment of HIV infection, " Nature, vol. 396, no. 6712, pp. 690-695, 1998.
37. B. D. Jamieson, D. C. Douek, S. Killian et al., "Generation of functional thymocytes in the human adult, " Immunity, vol. 10, no. 5, pp. 569-575, 1999.
38. D. Andrew and R. Aspinall, "Age-associated thymic atrophy is linked to a decline in IL-7 production, " Expimental Gerontology, vol. 37, no. 2-3, pp. 455-463, 2002.
39. G. D. Sempowski, M. E. Gooding, H. X. Liao, P. T. Le, and B. F. Haynes, "T cell receptor excision circle assessment of thymopoiesis in aging mice, " Molecular Immunology, vol. 38, no. 11, pp. 841-848, 2002.
40. J. A. Phillips, T. I. Brondstetter, C. A. English, H. E. Lee, E. L. Virts, and M. L. Thoman, "IL-7 gene therapy in aging restores early thymopoiesis without reversing involution, " Journal of Immunology, vol. 173, no. 8, pp. 4867-4874, 2004.
41. A. M. Wertheimer, M. Bennett, B. Park et al., "Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans, " Journal of Immunology, vol. 192, no. 5, pp. 2143-2155, 2014.
42. M. Czesnikiewicz-Guzik, W. W. Lee, D. Cui et al., "T cell subset-specific susceptibility to aging, " Clinical Immunology, vol. 127, no. 1, pp. 107-118, 2008.
43. M. V. Soares, N. J. Borthwick, M. K. Maini, G. Janossy, M. Salmon, and A. N. Akbar, "IL-7-dependent extrathymicexpansion of CD45RA+ T cells enables preservation of a naive repertoire, " Journal of Immunology, vol. 161, no. 11, pp. 5909-5917, 1998.
44. C. D. Surh and J. Sprent, "Homeostasis of naive and memory T cells, " Immunity, vol. 29, no. 6, pp. 848-862, 2008.
45. T. J. Fry and C. L. Mackall, "The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance, " Journal of Immunology, vol. 174, no. 11, pp. 6571-6576, 2005.
46. M. L. Pekalski, R. C. Ferreira, R. M. R. Coulson et al., "Postthymic expansion in human CD4 naive T cells defined by expression of functional high-affinity IL-2 receptors, " The Journal of Immunology, vol. 190, no. 6, pp. 2554-2566, 2013.
47. R. D. Kilpatrick, T. Rickabaugh, L. E. Hultin et al., "Homeostasis of the naive CD4+ T cell compartment during aging, " The Journal of Immunology, vol. 180, no. 3, pp. 1499-1507, 2008.
48. Q. Qi, Y. Cheng, J. Glanville et al., "Diversity and clonal selection in the human T-cell repertoire, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 36, pp. 13139-13144, 2014.
49. W. M. Passtoors, J. M. Boer, J. J. Goeman et al., "Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7R, " PloS One, vol. 7, no. 1, Article ID e27759, 2012.
50. E. Derhovanessian, A. B. Maier, R. Beck et al., "Hallmark features of immunosenescence are absent in familial longevity, " Journal of Immunology, vol. 185, no. 8, pp. 4618-4624, 2010.
51. A. T. Waickman, J. Y. Park, and J. H. Park, "The common γ-chain cytokine receptor: tricks-and-treats for T cells, " Cellular and Molecular Life Sciences: CMLS, vol. 73, no. 2, pp. 253-269, 2016.
52. S. T. R. Walsh, "Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway, " Immunological Reviews, vol. 250, no. 1, pp. 303-316, 2012.
53. S. Demehri, M. Morimoto, M. J. Holtzman, and R. Kopan, "Skin-derived TSLP triggers progression from epidermalbarrier defects to asthma, " PLoS Biology, vol. 7, no. 5, Article ID e1000067, 2009.
54. S. Ebner, V. A. Nguyen, M. Forstner et al., "Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells, " Journal of Allergy and Clinical Immunology, vol. 119, no. 4, pp. 982-990, 2007.
55. K. Koyama, T. Ozawa, K. Hatsushika et al., "A possible role for TSLP in inflammatory arthritis, " Biochemical and Biophysical Research Communications, vol. 357, no. 1, pp. 99-104, 2007.
56. K. Ghoreschi, A. Laurence, and J. J. OShea, "Janus kinases in immune cell signaling, " Immunological Reviews, vol. 228, no. 1, pp. 273-287, 2009.
57. A. Puel, S. F. Ziegler, R. H. Buckley, and W. J. Leonard, "Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency, " Nature Genetics, vol. 20, no. 4, pp. 394-397, 1998.
58. A. M. Crawley and J. B. Angel, "The influence of HIV on CD127 expression and its potential implications for IL-7 therapy, " Seminars in Immunology, vol. 24, no. 3, pp. 231-240, 2012.
59. M. Pellegrini, T. Calzascia, J. G. Toe et al., "IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology, " Cell, vol. 144, no. 4, pp. 601-613, 2011.
60. C. R. Burtner and B. K. Kennedy, "Progeria syndromes and ageing: what is the connection?" Nature Reviews. Molecular Cell Biology, vol. 11, no. 8, pp. 567-578, 2010.
61. M. M. Cavanagh, C. M. Weyand, and J. J. Goronzy, "Chronic inflammation and aging: DNA damage tips the balance, " Current Opinion in Immunology, vol. 24, no. 4, pp. 488-493, 2012.
62. L. Shao, H. Fujii, I. Colmegna, H. Oishi, J. J. Goronzy, and C. M. Weyand, "Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis, " The Journal of Experimental Medicine, vol. 206, no. 6, pp. 1435-1449, 2009.
63. H. Fujii, L. Shao, I. Colmegna, J. J. Goronzy, and C. M. Weyand, "Telomerase insufficiency in rheumatoid arthritis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 11, pp. 4360-4365, 2009.
64. C. B. Park and N. G. Larsson, "Mitochondrial DNA mutations in disease and aging, " The Journal of Cell Biology, vol. 193, no. 5, pp. 809-818, 2011.
65. O. A. Ross, P. Hyland, M. D. Curran et al., "Mitochondrial DNA damage in lymphocytes: a role in immunosenescence?" Expimental Gerontology, vol. 37, no. 2-3, pp. 329-340, 2002.
66. J. Lin, E. Epel, J. Cheon et al., "Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance, " Journal of Immunological Methods, vol. 352, no. 1-2, pp. 71-80, 2010.
67. Y. Lin, A. Damjanovic, E. J. Metter et al., "Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions, " Clinical Science, vol. 128, no. 6, pp. 367-377, 2015.
68. N. P. Weng, B. L. Levine, C. H. June, and R. J. Hodes, "Human naive and memory T lymphocytes differ in telomeric length and replicative potential, " Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 24, pp. 11091-11094, 1995.
69. G. Pawelec, A. Akbar, C. Caruso, R. Effors, B. Gruebeck-Loebenstein, and A. Wikby, "Is immunosenescence infectious?" Trends in Immunology, vol. 25, no. 8, pp. 406-410, 2004.
70. B. Brazvan, R. Farahzadi, S. M. Mohammadi et al., "Key immune cell cytokines affects the telomere activity of cord blood cells in vitro, " Advanced Pharmaceutical Bulletin, vol. 6, no. 2, pp. 153-161, 2016.
71. J. M. Lord, A. N. Akbar, and D. Kipling, "Telomere-based therapy for immunosenescence, " Trends in Immunology, vol. 23, no. 4, pp. 175-176, 2002.
72. C. M. Weyand, H. Fujii, L. Shao, and J. J. Goronzy, "Rejuvenating the immune system in rheumatoid arthritis, " Nature Reviews. Rheumatology, vol. 5, no. 10, pp. 583-588, 2009.
73. E. Sahin and R. A. Depinho, "Linking functional decline of telomeres, mitochondria and stem cells during ageing, " Nature, vol. 464, no. 7288, pp. 520-528, 2010.
74. E. Sahin, S. Colla, M. Liesa et al., "Telomere dysfunction induces metabolic and mitochondrial compromise, " Nature, vol. 470, no. 7334, pp. 359-365, 2011.
75. N. J. MacIver, R. D. Michalek, and J. C. Rathmell, "Metabolic regulation of T lymphocytes, " Annual Review of Immunology, vol. 31, pp. 259-283, 2013.
76. K. N. Pollizzi and J. D. Powell, "Integrating canonical and metabolic signalling programmes in the regulation of T cell responses, " Nature Reviews Immunology, vol. 14, no. 7, pp. 435-446, 2014.
77. X. Xu, K. Araki, S. Z. Li et al., "Autophagy is essential for effector CD8(+) T cell survival and memory formation, " Nature Immunology, vol. 15, no. 12, pp. 1152-1161, 2014.
78. R. Valdor, E. Mocholi, Y. Botbol et al., "Chaperone-mediated autophagy regulates T cell responses through targeted degradation of negative regulators of T cell activation, " Nature Immunology, vol. 15, no. 11, pp. 1046-1054, 2014.
79. L. W. Harries, A. D. Fellows, L. C. Pilling et al., "Advancing age is associated with gene expression changes resembling mTOR inhibition: evidence from two human populations, " Mechanisms of Ageing and Development, vol. 133, no. 8, pp. 556-562, 2012.
80. W. M. Passtoors, M. Beekman, J. Deelen et al., "Gene expression analysis of mTor pathway: association with human longevity, " Aging Cell, vol. 12, no. 1, pp. 24-31, 2013.
81. D. G. Hardie, "AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function, " Genes & Development, vol. 25, no. 18, pp. 1895-1908, 2011.
82. J. Rolf, M. Zarrouk, D. K. Finlay, M. Foretz, B. Viollet, and D. A. Cantrell, "AMPKα1: a glucose sensor that controls CD8 T-cell memory, " European Journal of Immunology, vol. 43, no. 4, pp. 889-896, 2013.
83. D. Finlay and D. A. Cantrell, "Metabolism, migration and memory in cytotoxic T cells, " Nature Reviews Immunology, vol. 11, no. 2, pp. 109-117, 2011.
84. S. M. Henson, A. Lanna, N. E. Riddell et al., "p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells, " Journal of Clinical Investigation, vol. 124, no. 9, pp. 4004-4016, 2014.
85. V. I. Brown, J. Hulitt, J. Fish et al. "Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling, " Cancer Research, vol. 67, 20, 9963-9970, 2007.
86. W. Ouyang, O. Beckett, R. A. Flavell, and M. O. Li, "An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance, " Immunity, vol. 30, no. 3, pp. 358-371, 2009.
87. Y. M. Kerdiles, D. R. Beisner, R. Tinoco et al., "Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor, " Nature Immunology, vol. 10, no. 2, pp. 176-184, 2009.
88. A. S. Lazorchak, D. Liu, V. Facchinetti et al., "Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells, " Molecular Cell, vol. 39, no. 3, pp. 433-443, 2010.
89. C. Chen, Y. Liu, Y. Liu, and P. Zheng, "mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells, " Science Signaling, vol. 2, no. 98, p. ra75, 2009.
90. C. Franceschi, M. Bonafe, S. Valensin et al., "Inflammaging. An evolutionary perspective on immunosenescence, " Annals of the New York Academy of Sciences, vol. 908, pp. 244-254, 2000.
91. C. Franceschi and J. Campisi, "Chronic inflammation (inflammaging) and its potential contribution to ageassociated diseases, " The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 69, Supplement 1, pp. S4-S9, 2014.
92. D. J. Baker, T. Wijshake, T. Tchkonia et al., "Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders, " Nature, vol. 479, no. 7372, pp. 232-236, 2011.
93. K. Rubtsova, A. V. Rubtsov, M. P. Cancro, and P. Marrack, "Age-associated B cells: a T-bet-dependent effector with roles in protective and pathogenic immunity, " Journal of Immunology, vol. 195, no. 5, pp. 1933-1937, 2015.
94. M. Ratliff, S. Alter, D. Frasca, B. B. Blomberg, and R. L. Riley, "In senescence, age-associated B cells secrete TNFα and inhibit survival of B-cell precursors, " Experimental Gerontology, vol. 12, no. 2, pp. 303-311, 2013.
95. I. den Braber, T. Mugwagwa, N. Vrisekoop et al., "Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans, " Immunity, vol. 36, no. 2, pp. 288-297, 2012.
96. Q. Qi, D. W. Zhang, C. N. Weyand, and J. J. Goronzy, "Mechanisms shaping the naive T cell repertoire in the elderly-thymic involution or peripheral homeostatic proliferation?" Experimental Gerontology, vol. 54, pp. 71-74, 2014.
97. J. Sprent and C. D. Surh, "Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells, " Nature Immunology, vol. 12, no. 6, pp. 478-484, 2011.
98. J. Reynolds, M. Coles, G. Lythe, and C. Molina-Paris, "Mathematical model of naive T cell division and survival IL-7 thresholds, " Frontiers in Immunology, vol. 4, p. 434, 2013.
99. K. R. Renkema, G. Li, A. Wu, M. J. Smithey, and J. NikolichZugich, "Two separate defects affecting true naive or virtual memory T cell precursors combine to reduce naive T cell responses with aging, " Journal of Immunology, vol. 192, no. 1, pp. 151-159, 2014.
100. J. J. Goronzy, G. Li, Z. Yang, and C. M. Weyand, "The janus head of T cell aging-autoimmunity and immunodeficiency, " Frontiers in Immunology, vol. 4, p. 131, 2013.
101. A. Bikker, C. E. Hack, F. P. Lafeber, and J. A. van Roon, "Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction, " Current Pharmaceutical Design, vol. 18, no. 16, pp. 2347-2356, 2012.
102. S. K. Lee, E. K. Jeon, Y. J. Kim et al., "A global gene expression analysis of the peripheral blood mononuclear cells reveals the gene expression signature in psoriasis, " Annals of Dermatology, vol. 21, no. 3, pp. 237-242, 2009.
103. F. T. Liu and G. A. Rabinovich, "Galectins: regulators of acute and chronic inflammation, " Annals of the New York Academy of Sciences, vol. 1183, pp. 158-182, 2010.
104. E. F. McKinney, P. A. Lyons, E. J. Carr et al., "A CD8+ T cell transcription signature predicts prognosis in autoimmune disease, " Nature Medicine, vol. 16, no. 5, pp. 586-591, 2010.
105. J. A. Todd, N. M. Walker, J. D. Cooper et al., "Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes, " Nature Genetics, vol. 39, no. 7, pp. 857-864, 2007.
106. P. L. De Jager, X. Jia, J. Wang et al., "Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci, " Nature Genetics, vol. 41, no. 7, pp. 776-782, 2009.
107. International Multiple Sclerosis Genetics Consortium, D. A. Hafler, A. Compston et al., "Risk alleles for multiple sclerosis identified by a genomewide study, " The New England Journal of Medicine, vol. 357, no. 9, pp. 851-862, 2007.
108. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, S. Sawcer et al., "Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis, " Nature, vol. 476, no. 7359, pp. 214-219, 2011.
109. C. A. Anderson, G. Boucher, C. W. Lees et al., "Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, " Nature Genetics, vol. 43, no. 3, pp. 246-252, 2011.
110. M. Nakamura, N. Nishida, M. Kawashima et al., "Genomewide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population, " American Journal of Human Genetics, vol. 91, no. 4, pp. 721-728, 2012.
111. J. T. Barata, A. A. Cardoso, L. M. Nadler, and V. A. Boussiotis, "Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1), " Blood, vol. 98, no. 5, pp. 1524-1531, 2001.
112. C. Shochat, N. Tal, O. R. Bandapalli et al., "Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias, " The Journal of Experimental Medicine, vol. 208, no. 5, pp. 901-908, 2011.
113. P. P. Zenatti, D. Ribeiro, W. Li et al., "Oncogenic IL7R gain-offunction mutations in childhood T-cell acute lymphoblastic leukemia, " Nature Genetics, vol. 43, no. 10, pp. 932-939, 2011.
114. P. E. Kovanen and W. J. Leonard, "Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways, " Immunological Reviews, vol. 202, pp. 67-83, 2004.
115. J. M. Franco, "T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy, " Blood, vol. 99, no. 10, pp. 3702-3706, 2002.
116. O. DelaRosa, G. Pawelec, E. Peralbo et al., "Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity, " Biogerontology, vol. 7, no. 5-6, pp. 471-481, 2006.
117. R. de la Rosa and M. Leal, "Thymic involvement in recovery of immunity among HIV-infected adults on highly active antiretroviral therapy, " Journal of Antimicrobial Chemotherapy, vol. 52, no. 2, pp. 155-158, 2003.
118. G. L. Goldberg, J. L. Zakrzewski, M. A. Perales, and M. R. van den Brink, "Clinical strategies to enhance T cell reconstitution, " Seminars in Immunology, vol. 19, no. 5, pp. 289-296, 2007.
119. A. Shanker, "Is thymus redundant after adulthood?" Immunology Letters, vol. 91, no. 2-3, pp. 79-86, 2004.
120. C. Sportes, F. T. Hakim, S. A. Memon et al., "Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, " The Journal of Experimental Medicine, vol. 205, no. 7, pp. 1701-1714, 2008.
121. C. M. Capitini, A. A. Christi, and C. L. Mackall, "Modulating Tcell homeostasis with IL-7: preclinical and clinical studies, " Journal of Internal Medicine, vol. 266, no. 2, pp. 141-153, 2009.
122. A. Ido and T. Hirohito, "Translational research to identify clinical applications of hepatocyte growth factor, " Hepatology Research, vol. 39, no. 8, pp. 739-747, 2009.
123. S. A. Rosenberg, C. Sportes, M. Ahmadzadeh et al., "IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells, " Journal of Immunotherapy, vol. 29, no. 3, pp. 313-319, 2006.
124. C. Sportes, R. R. Babb, M. C. Krumlauf et al., "Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy, " Clinical Cancer Research, vol. 16, no. 2, pp. 727-735, 2010.
125. J. A. Levy, "HIV pathogenesis: 25 years of progress and persistent challenges, " AIDS, vol. 23, no. 2, pp. 147-160, 2009.
126. I. Sereti, R. M. Dunham, J. Spritzler et al., "IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection, " Blood, vol. 113, no. 25, pp. 6304-6314, 2009.
127. Z. J. Yang, S. L. Xu, B. Chen et al., "Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease, " Clinical and Experimental Pharmacology & Physiology, vol. 26, no. 8, pp. 790-796, 2009.
128. Z. Wang, S. Sandiford, C. Wu, and S. S. Li, "Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signaling, " The EMBO Journal, vol. 28, no. 16, pp. 2360-2373, 2009.
129. Z. J. Yang, Y. R. Zhang, B. Chen et al., "Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease, " Molecular Biology Reports, vol. 36, no. 6, pp. 1323-1329, 2009.
130. H. Nakagami, Y. Kaneda, T. Ogihara, and R. Morishita, "Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis, " Current Diabetes Reviews, vol. 1, no. 1, pp. 59-63, 2005.
131. B. Yuan, Z. Zhao, Y. R. Zhang et al., "Short-term safety and curative effect of recombinant adenovirus carrying hepatocyte growth factor gene on ischemic cardiac disease, " In Vivo, vol. 22, no. 5, pp. 629-632, 2008.
132. R. J. Powell, M. Simons, F. O. Mendelsohn et al., "Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia, " Circulation, vol. 118, no. 1, pp. 58-65, 2008.
133. R. Morishita, M. Aoki, N. Hashiya et al., "Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease, " Hypertension, vol. 44, no. 2, pp. 203-209, 2004.
134. S. D. McKenna, F. Chen, L. Lai, and I. Goldschneider, "Identification of an IL-7-associated pre-pro-B cell growthstimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 genedeleted mice, " Journal of Immunology, vol. 160, no. 5, pp. 2272-2279, 1998.
135. L. Lai, F. Chen, S. McKenna, and I. Goldschneider, "Identification of an IL-7-associated pre-pro-B cell growthstimulating factor (PPBSF). II. PPBSF is a covalently linked heterodimer of IL-7 and a Mr 30, 000 cofactor, " Journal of Immunology, vol. 160, no. 5, pp. 2280-2286, 1998.
136. L. Lai and I. Goldschneider, "Cutting edge: identification of a hybrid cytokine consisting of IL-7 and the beta-chain of the hepatocyte growth factor/scatter factor, " Journal of Immunology, vol. 167, no. 7, pp. 3550-3554, 2001.
137. J. S. Rubin, D. P. Bottaro, and S. A. Aaronson, "Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product, " Biochimica et Biophysica Acta, vol. 1155, no. 3, pp. 357-371, 1993.
138. R. Zarnegar and G. K. Michalopoulos, "The many faces of hepatocyte growth factor: from hepatopoiesis tohematopoiesis, " The Journal of Cell Biology, vol. 129, no. 5, pp. 1177-1180, 1995.
139. T. Nishino, H. Hisha, N. Nishino, M. Adachi, and S. Ikehara, "Hepatocyte growth factor as a hematopoietic regulator, " Blood, vol. 85, no. 11, pp. 3093-3100, 1995.
140. S. Tamura, T. Sugawara, Y. Tokoro et al., "Expression and function of c-Met, a receptor for hepatocyte growth factor, during T-cell development, " Scandinavian Journal of Immunology, vol. 47, no. 4, pp. 296-301, 1998.
141. R. van der Voort, T. E. Taher, R. M. Keehnen, L. Smit, M. Groenink, and S. T. Pals, "Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway, " Journal of Experimental Medicine, vol. 185, no. 12, pp. 2121-2131, 1997.
142. C. Wei, L. Lai, and I. Goldschneider, "Pre-pro-B cell growthstimulating factor (PPBSF) upregulates IL-7Ralpha chain expression and enables pro-B cells to respond to monomeric IL-7, " Journal of Interferon & Cytokine Research, vol. 22, no. 7, pp. 823-832, 2002.
143. L. Lai, R. A. Zeff, and I. Goldschneider, "A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and prepro-B cells, " Blood, vol. 107, no. 5, pp. 1776-1784, 2006.
144. R. Hu, Y. Liu, Y. Song et al., "Recombinant IL-7/HGFβ hybrid cytokine separates acute graft-versus-host-disease from graft-versus-tumour activity by altering donor T cell trafficking, " British Journal of Haematology, vol. 175, no. 3, pp. 505-516, 2016.
145. R. Thiebaut, A. Jarne, J. P. Routy et al., "Repeated cycles of recombinant human interleukin 7 in HIV-infected patients with low CD4 T-cell reconstitution on antiretroviral therapy: results of 2 phase II multicenter studies, " Clinical Infectious Diseases, vol. 62, no. 9, pp. 1178-1185, 2016.
146. N. K. Patil, J. K. Bohannon, and E. R. Sherwood, "Immunotherapy: a promising approach to reverse sepsis-induced immunosuppression, " Pharmacological Research, vol. 111, pp. 688-702, 2016.
147. Y. Shindo, A. G. Fuchs, C. G. Davis et al., "Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia, " Journal of Leukocyte Biology, vol. 101, no. 2, pp. 543-554, 2017.
148. V. Sheikh, B. O. Porter, R. DerSimonian et al., "Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia, " Blood, vol. 127, no. 8, pp. 977-988, 2016.
149. M. C. Kang, D. H. Choi, Y. W. Choi et al., "Intranasal introduction of Fc-fused interleukin-7 provides long-lasting prophylaxis against lethal influenza virus infection, " Journal of Virology, vol. 90, no. 5, pp. 2273-2284, 2015.
150. S. S. Ahn, B. Y. Jeon, S. J. Park et al., "Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis, " Vaccine, vol. 31, no. 27, pp. 2884-2890, 2013.
151. S. H. Park, M. Y. Song, H. J. Nam, S. J. Im, and Y. C. Sung, "Codelivery of IL-7 augments multigenic HCV DNA vaccine-induced antibody as well as broad T cell responses in Cynomolgus monkeys, " Immune Network, vol. 10, no. 6, pp. 198-205, 2010.
152. H. J. Nam, M. Y. Song, D. H. Choi, S. H. Yang, H. T. Jin, and Y. C. Sung, "Marked enhancement of antigen-specific T-cell responses by IL-7-fused nonlytic, but not lytic, Fc as a genetic adjuvant, " European Journal of Immunology, vol. 40, no. 2, pp. 351-358, 2010.
153. W. Zou, "Immunosuppressive networks in the tumour environment and their therapeutic relevance, " Nature Reviews. Cancer, vol. 5, no. 4, pp. 263-274, 2005.
154. C. Baecher-Allan and D. A. Hafler, "Suppressor T cells in human diseases, " The Journal of Experimental Medicine, vol. 200, no. 3, pp. 273-276, 2004.
155. B. D. Johnson, W. Jing, and R. J. Orentas, "CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma, " Journal of Immunotherapy, vol. 30, no. 2, pp. 203-214, 2007.
156. A. M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein, "Increase of regulatory T cells in the peripheral blood of cancer patients, " Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, vol. 9, no. 2, pp. 606-612, 2003.
157. E. Y. Woo, C. S. Chu, T. J. Goletz et al., "Regulatory CD4(+)CD25(+) T cells in tumors from patients with earlystage non-small cell lung cancer and late-stage ovarian cancer, " Cancer Research, vol. 61, no. 12, pp. 4766-4772, 2001.
158. T. J. Curiel, G. Coukos, L. Zou et al., "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, " Nature Medicine, vol. 10, no. 9, pp. 942-949, 2004.
159. S. A. Rosenberg, N. P. Restifo, J. C. Yang, R. A. Morgan, and M. E. Dudley, "Adoptive cell transfer: a clinical path to effective cancer immunotherapy, " Nature Reviews. Cancer, vol. 8, no. 4, pp. 299-308, 2008.
160. M. Ahmadzadeh and S. A. Rosenberg, "IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients, " Blood, vol. 107, no. 6, pp. 2409-2414, 2006.
161. W. Liu, A. L. Putnam, Z. Xu-Yu et al., "CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, " The Journal of Experimental Medicine, vol. 203, no. 7, pp. 1701-1711, 2006.
162. J. F. Vera, V. Hoyos, B. Savoldo et al., "Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7, " Molecular Therapy, vol. 17, no. 5, pp. 880-888, 2009.
163. S. K. Perna, D. Pagliara, A. Mahendravada et al., "Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition, " Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, vol. 20, no. 1, pp. 131-139, 2014.